0J8P Stock Overview
IDEXX Laboratories, Inc. develops, manufactures, and distributes products primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets in Africa, the Asia Pacific, Canada, Europe, Latin America, and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 3/6 |
| Past Performance | 6/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
No risks detected for 0J8P from our risk checks.
IDEXX Laboratories, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$481.65 |
| 52 Week High | US$583.30 |
| 52 Week Low | US$373.77 |
| Beta | 1.26 |
| 1 Month Change | -9.79% |
| 3 Month Change | -7.99% |
| 1 Year Change | -0.64% |
| 3 Year Change | -11.74% |
| 5 Year Change | 113.99% |
| Change since IPO | 229.90% |
Recent News & Updates
Recent updates
Shareholder Returns
| 0J8P | GB Medical Equipment | GB Market | |
|---|---|---|---|
| 7D | -5.1% | -1.4% | -1.4% |
| 1Y | -0.6% | -7.8% | -2.4% |
Return vs Industry: 0J8P exceeded the UK Medical Equipment industry which returned -7.8% over the past year.
Return vs Market: 0J8P exceeded the UK Market which returned -2.4% over the past year.
Price Volatility
| 0J8P volatility | |
|---|---|
| 0J8P Average Weekly Movement | 3.8% |
| Medical Equipment Industry Average Movement | 7.9% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in GB Market | 11.5% |
| 10% least volatile stocks in GB Market | 2.7% |
Stable Share Price: 0J8P has not had significant price volatility in the past 3 months.
Volatility Over Time: 0J8P's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1983 | 11,000 | Jay Mazelsky | www.idexx.com |
IDEXX Laboratories, Inc. develops, manufactures, and distributes products primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets in Africa, the Asia Pacific, Canada, Europe, Latin America, and internationally. The company operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. It also provides point-of-care veterinary diagnostic products, including instruments, consumables, and rapid assay test kits; veterinary reference laboratory diagnostic and consulting services; practice management and diagnostic imaging systems and services for veterinarians; and health monitoring, biological materials testing, and laboratory diagnostic instruments, and services for biomedical research community.
IDEXX Laboratories, Inc. Fundamentals Summary
| 0J8P fundamental statistics | |
|---|---|
| Market cap | US$39.74b |
| Earnings (TTM) | US$845.04m |
| Revenue (TTM) | US$3.66b |
47.0x
P/E Ratio10.8x
P/S RatioIs 0J8P overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 0J8P income statement (TTM) | |
|---|---|
| Revenue | US$3.66b |
| Cost of Revenue | US$1.47b |
| Gross Profit | US$2.19b |
| Other Expenses | US$1.34b |
| Earnings | US$845.04m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
May 01, 2024
| Earnings per share (EPS) | 10.17 |
| Gross Margin | 59.82% |
| Net Profit Margin | 23.08% |
| Debt/Equity Ratio | 63.9% |
How did 0J8P perform over the long term?
See historical performance and comparison